Obama's Coming Stem-Cell Decision May Not Jump-Start Research
By Paul Basken,
Chronicle of Higher Education
| 02. 05. 2009
Eight years ago, President George W. Bush sharply limited federal support for stem-cell research. The move cost universities millions of dollars while slowing the hunt for life-saving medical advances. And it may now be only days before President Obama reverses course.
But for all the trouble the presidential restriction has caused, and for all the political trauma that may accompany a cancellation of Mr. Bush's order, both the science and the economics have evolved so far since 2001 that universities may feel affected far less by Mr. Obama's decision than they were by Mr. Bush's. Still, an obscure piece of legislation called the Dickey-Wicker Amendment may remain an obstacle no matter what the president does.
Mr. Obama's anticipated reversal of policy "won't be a boon the way some people might think," said Arnold R. Kriegstein, director of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at the University of California at San Francisco. "Time has moved on, and so has the field."
Stem cells are capable of growing into any type of cell of the...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...